United States· US:51144-003_62959a22-02f7-463c-80bb-3c5e621b1f58
TIVDAK
A tisotumab vedotin product containing tisotumab vedotin, registered in United States by SEAGEN INC.. The same ATC class is registered in 10 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Tisotumab vedotin is registered in 10 of 19 countries.
Countries holding a registration under ATC L01FX23 (tisotumab vedotin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 6 of them publish a price we can compare per daily dose
Tisotumab vedotin · ATC L01FX23
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- TISOTUMAB VEDOTIN
- Manufacturer
- SEAGEN INC.
- Country
- United States (US)
- ATC code
- L01FX23
- ATC class
- Tisotumab vedotin
- Defined daily dose
- 6.67 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1151144-003-01
- ndc1151144003011 VIAL in 1 CARTON (51144-003-01) / 4 mL in 1 VIAL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tisotumab vedotin in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumTivdak 40 mgGenmab
- CzechiaTIVDAKGENMAB A/S, Valby
- SpainTIVDAK 40 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONGenmab A/S
- FinlandTivdakGenmab A/S
- United KingdomTivdak 40mg powder for concentrate for solution for infusion vialsGenmab A/S
- IrelandTivdak 40 mg powder for concentrate for solution for infusionGenmab A/S
- IcelandTivdakGenmab A/S
- Japanチソツマブ ベドチン（遺伝子組換え）ジェンマブ
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Tivdak
- Liechtenstein · Tivdak
- Norway · Tivdak
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ec062234-ba71-40d9-862c-cb478ef5b3b4 GET /v1/drugs/ec062234-ba71-40d9-862c-cb478ef5b3b4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "40",
"substance": "TISOTUMAB VEDOTIN",
"productndc": "51144-003",
"dosage_form": "INJECTION, POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/4mL",
"application_number": "BLA761208",
"marketing_category": "BLA"
}See everything about tisotumab vedotin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.